Skip to main
AMTX
AMTX logo

Aemetis (AMTX) Stock Forecast & Price Target

Aemetis (AMTX) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 13%
Sell 13%
Strong Sell 0%

Bulls say

Aemetis Inc., a renewable fuel and biochemicals company, is projected to experience significant revenue growth, with an expected increase from $398 million in 2025 to $1.8 billion by 2036, reflecting a robust eleven-year compound annual growth rate (CAGR) of approximately 14.4%. The company's operations are bolstered by solid execution and an upcoming rebound in its India segment, along with the potential for improved cash flows from its renewable natural gas business and an IPO of its biodiesel operations in 2025, which could enhance its balance sheet. Additionally, while operating expenses are anticipated to rise at a CAGR of 8.9%, the overall outlook for Aemetis remains positive, suggesting substantial upside potential from the current share price.

Bears say

Aemetis Inc. experienced a significant decline in revenue from its India operations, with Q4 revenues dropping to $3 million from $32 million in Q3 2024. The company's net loss for fiscal Q4 2024 stood at $16.2 million, translating to a loss of $0.36 per share, although this was an improvement compared to a net loss of $25.4 million and a loss of $0.64 per share in the previous year’s fourth quarter. Additionally, the reported EPS of $(0.36) was slightly better than the estimated $(0.32), yet still fell within a disappointing range relative to market expectations of $(0.41).

Aemetis (AMTX) has been analyzed by 8 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 13% suggest Holding, 13% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aemetis and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aemetis (AMTX) Forecast

Analysts have given Aemetis (AMTX) a Buy based on their latest research and market trends.

According to 8 analysts, Aemetis (AMTX) has a Buy consensus rating as of Aug 2, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aemetis (AMTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.